Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-01

Clinical Trial Update: Cangpo Liujun Prescription on Cancer-related Fatigue in Advanced Colorectal Cancer With Spleen Deficiency and Dampness Excess [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Cangpo Liujun Prescription for cancer-related fatigue in advanced colorectal cancer; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cangpo Liujun Prescription

Snippet

Sponsor: First People's Hospital of Hangzhou | Conditions: Cancer-Related Fatigue, Colorectal Cancer | Phase 2 | Status: RECRUITING